Home
Conditions
Recurrence

Clinical trial condition

Recurrence

Explore clinical trials studying Recurrence. Study availability and eligibility vary by location and protocol.

2,308 public trials 520 recruiting studies

Refine in advanced search Browse all conditions

Recurrence trial results

Active, Not Recruiting

Study Comparing Continuous Versus Fixed Duration Therapy With Daratumumab, Lenalidomide, and Dexamethasone for Relapsed Multiple Myeloma

NCT03836014

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
Locations: Saint Antoine Hospital - Hematology Department Paris, France

View Trial Details

Active, Not Recruiting

Pomalidomide in Relapsed and Refractory Multiple Myeloma (RRMM)

NCT02406222

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations: Belfast Health & Social Care Trust Belfast, United Kingdom

University of Birmingham NHS Foundation Trust Birmingham, United Kingdom

Birmingham Heartlands Hospital Birmingham, United Kingdom

Royal Sussex County Hospital Brighton, United Kingdom

View all 21 locations

View Trial Details

Active, Not Recruiting

StayFine: Personalised Relapse Prevention of Anxiety and Mood Disorders in Youths

NCT05551468

Conditions: Anxiety Disorders, Behavior, Depressive Disorder, +8 more
Locations: GGZ Oost Brabant Boekel, Netherlands

View Trial Details

Active, Not Recruiting

OSE2101 Alone or in Combination With Pembrolizumab vs BSC in Patient With Platinum-sensitive Recurrent OC

NCT04713514

Conditions: Adnexal Diseases, Disease Attributes, Endocrine Gland Neoplasms, +18 more
Locations: UZ Leuven Leuven, Belgium

Centre Hospitalier de l'Ardenne Vivalia Libramont, Belgium

Centre Hospitalier Universitaire de Liège Liège, Belgium

ICO Paul Papin Angers, France

View all 40 locations

View Trial Details

Active, Not Recruiting

A Study to Determine the Recommended Dose and Regimen and to Evaluate the Safety and Preliminary Efficacy of CC-92480 in Combination With Standard Treatments in Participants With Relapsed or Refractory Multiple Myeloma (RRMM) and Newly Diagnosed Multiple Myeloma (NDMM)

NCT03989414

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations: Local Institution - 119 Denver, Colorado, United States

Local Institution - 104 Tampa, Florida, United States

Local Institution - 108 Atlanta, Georgia, United States

Local Institution - 112 Chicago, Illinois, United States

View all 49 locations

View Trial Details

Active, Not Recruiting

Pazopanib Vs. Pazopanib Plus Gemcitabine

NCT02203760

Conditions: Carcinosarcoma, Disease Attributes, Leiomyosarcoma, +10 more
Locations: Universitätsklinikum Bonn Bonn, Germany

Helios Klinikum Berlin-Buch, Klinik für Onkologie und Paliativmedizin Berlin, Germany

Universitätsmedizin Greifswald Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe Greifswald, Germany

Helios Klinikum Bad Saarow, Hämatologie, Onkologie und Palliativmedizin, Sarkomzentrum Bad Saarow, Germany

View Trial Details

Active, Not Recruiting

Hippocampal Sparing Whole Brain Radiation Versus Stereotactic Radiation in Patients With 5-20 Brain Metastases: A Phase III, Randomized Trial

NCT03075072

Conditions: Adenocarcinoma, Brain Diseases, Brain Metastases, +40 more
Locations: Brigham and Women's Hospital Boston, Massachusetts, United States

Dana Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Active, Not Recruiting

Primary Care Transfer for Thyroid Cancer Patients

NCT03794375

Conditions: Differentiated Thyroid Cancer, Disease Attributes, Pathologic Processes, +2 more
Locations: Hospital de Clínicas de Porto Alegre Porto Alegre, Brazil

View Trial Details

Active, Not Recruiting

A Phase 1 Study of SHR2554 in Subjects With Relapsed or Refractory Mature Lymphoid Neoplasms

NCT03603951

Conditions: Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, +2 more
Locations: Beijing Cancer Hospital, Peking University Beijing, Beijing Municipality, China

View Trial Details

Active, Not Recruiting

Seeded Cells on Matrix Plug Treating Crohn's Perianal Fistulas (STOMP-II)

NCT04847739

Conditions: Crohn Disease, Crohn's Disease, Digestive System Diseases, +9 more
Locations: Mayo Clinic Arizona Phoenix, Arizona, United States

Office of Phillip Fleshner, MD Los Angeles, California, United States

Stanford University Redwood City, California, United States

UC Davis Sacramento, California, United States

View all 15 locations

View Trial Details

Recurrence

Recurrence trial results

Related conditions